Midsona AB Series B
Midsona AB (publ), a consumer goods company, provides organic and consumer health products, and health food products in Sweden, Denmark, Finland, Norway, France, Spain, Germany, Rest of Europe, and internationally. The company offers plant-based food, such as grains, flakes, seeds, vegetables, pasta, and rice; bread, beverages, cold cuts, dinner accessories, pasta sauce, pesto, sugar, syrup, nuts… Read more
Midsona AB Series B (0GSE) - Net Assets
Latest net assets as of December 2021: Skr2.88 Billion SEK
Based on the latest financial reports, Midsona AB Series B (0GSE) has net assets worth Skr2.88 Billion SEK as of December 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr5.29 Billion) and total liabilities (Skr2.41 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr2.88 Billion |
| % of Total Assets | 54.38% |
| Annual Growth Rate | 16.7% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 16.89 |
Midsona AB Series B - Net Assets Trend (2017–2021)
This chart illustrates how Midsona AB Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Midsona AB Series B (2017–2021)
The table below shows the annual net assets of Midsona AB Series B from 2017 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | Skr2.88 Billion | +24.30% |
| 2020-12-31 | Skr2.31 Billion | -0.39% |
| 2019-12-31 | Skr2.32 Billion | +42.45% |
| 2018-12-31 | Skr1.63 Billion | +5.16% |
| 2017-12-31 | Skr1.55 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Midsona AB Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr880.00 Million | 30.61% |
| Common Stock | Skr363.00 Million | 12.63% |
| Other Components | Skr1.63 Billion | 56.77% |
| Total Equity | Skr2.88 Billion | 100.00% |
Midsona AB Series B Competitors by Market Cap
The table below lists competitors of Midsona AB Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
$46.10 Million |
|
Malindo Feedmill Tbk
JK:MAIN
|
$46.12 Million |
|
Iodm Ltd
AU:IOD
|
$46.15 Million |
|
Beyond Securities PCL
BK:BYD
|
$46.15 Million |
|
Dynamic Cables Limited
NSE:DYCL
|
$46.07 Million |
|
BioSmart Co.Ltd
KQ:038460
|
$46.07 Million |
|
Exagen Inc
NASDAQ:XGN
|
$46.05 Million |
|
Signpost India Limited
NSE:SIGNPOST
|
$46.05 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Midsona AB Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 2,313,000,000 to 2,875,000,000, a change of 562,000,000 (24.3%).
- Net income of 89,000,000 contributed positively to equity growth.
- Dividend payments of 86,000,000 reduced retained earnings.
- Share repurchases of 500,000,000 reduced equity.
- Other factors increased equity by 1,059,000,000.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr89.00 Million | +3.1% |
| Dividends Paid | Skr86.00 Million | -2.99% |
| Share Repurchases | Skr500.00 Million | -17.39% |
| Other Changes | Skr1.06 Billion | +36.83% |
| Total Change | Skr- | 24.30% |
Book Value vs Market Value Analysis
This analysis compares Midsona AB Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Midsona AB Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.36%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 1.84x
- Recent ROE (3.10%) is below the historical average (5.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 5.42% | 3.91% | 0.75x | 1.84x | Skr-71.00 Million |
| 2018 | 7.91% | 4.52% | 0.77x | 2.27x | Skr-34.00 Million |
| 2019 | 4.18% | 3.15% | 0.64x | 2.06x | Skr-135.20 Million |
| 2020 | 7.61% | 4.75% | 0.72x | 2.22x | Skr-55.30 Million |
| 2021 | 3.10% | 2.36% | 0.71x | 1.84x | Skr-198.50 Million |
Industry Comparison
This section compares Midsona AB Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Midsona AB Series B (0GSE) | Skr2.88 Billion | 5.42% | 0.84x | $46.08 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |